MedTrace Logo

Studying a Potential Protective Effect of L-Dopa on Retinitis Pigmentosa

NCT02837640 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2016-07-19

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effect of L-Dopa on the progression of retinitis pigmentosa.

Conditions

Interventions

DRUG

levodopa-carbidopa

sinemet 200/50 1/2 tablet b.i.d. for 2 days and then t.i.d for 6 months

Sponsors & Collaborators

  • Beirut Eye Specialist Hospital

    lead OTHER

Principal Investigators

  • Elias F. Jarade, MD · Beirut Eye Specialist Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
10 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2017-06-30
Completion
2021-06-30

Countries

  • Lebanon

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02837640 on ClinicalTrials.gov